Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-02-10 @ 2:55 PM
Study NCT ID:
NCT03478761
Status:
RECRUITING
Last Update Posted:
2025-04-04
First Post:
2018-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
Status:
RECRUITING
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
Detailed Description:
In this registry we propose to establish and maintain a registry of suspected and confirmed patients with 24 hydroxylase deficiency in an effort to collect data for further investigation. This would be the first and only known registry of its kind. These resources would be made widely available to clinicians and research scientists within Mayo to stimulate advances in the diagnosis and treatment of patients with this disease.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: